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Objectives: The objective of the current study is to analyze different approaches of pharmacists and general
practitioners towards availability and use of osteoporosis prescreening tools and to find out reasons that explain
non utilization of such tools in clinical practice.
Settings: Among General practitioners and Community pharmacists in Pulau Penang, Malaysia.
Methodology: An explorative cross sectional study was carried out using convenience sampling approach.
A pre-validated self- administered questionnaire was used to carry out the study. A total of 170 healthcare
professionals participated in study.
Main outcome: Evaluation of awareness, use and opinions of healthcare professionals regarding osteoporosis
prescreening tools.
Results: Response rate of study was 56%. The mean age of the participants was 39.00 + 7.89 years.
Less than one third of participants were familiar with term prescreening tools or Clinical decision rules.
The only osteoporosis prescreening tool that was recognized and used by majority of participants was FRAX.
Participants agreed that low level of awareness regarding availability of prescreening tools poses hindrance in
utilization of such tools in clinical practice. Majority of participants showed willingness to gain information
and use such tools in future.
Conclusions: The results of our study demonstrate an urgent need of implementation of osteoporosis
prescreening tools educational and awareness programs among healthcare professionals.Introduction
Osteoporosis is a metabolic bone disease that has poten-
tial to reach epidemic proportion. The increase prevalence
of disease is attributed to low awareness of disease among
general population and failure on part of healthcare pro-
fessionals as far as diagnosis and management of disease is
concerned (Freedman & Kaplan 2000; Chenot & Scheidt-
Nave 2007). In order to increase awareness of osteoporosis
in both general and diseased population, various studies
have been conducted in different geographical settings
(Yusra & Azmi 2012; Pauline & Chua 2013). Unfortu-
nately, literature search shows paucity of data in terms of
healthcare professionals’ role in both diagnosis and man-
agement of disease. This is evident from the fact that* Correspondence: yusrahabib@ymail.com
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in any medium, provided the original work is ptreatment rate for osteoporosis differs significantly from
other medical conditions such as myocardial infarction for
which 75% of patients receive appropriate treatment while
only 10% of osteoporotic patients would receive adequate
treatment (Giangregorio & Papaioannou 2006; Austin &
Tu 2008). The reason for poor treatment rate of osteopor-
osis is attributed to the fact that unless a bone scan is done,
it is impossible to diagnose osteoporosis. As DXA (Dual X-
ray absorptiometry) is the gold standard for diagnosis of
osteoporosis, extremely high cost and limited availability
of DXA machines pose hindrance in timely diagnosis
of disease and hence provision of appropriate treatment to
patients suffering from osteoporosis (Gibson & Bogoch
2004). In order to cope up with current scenario, in the
middle of 1990’s, various osteoporosis Clinical decision
rules (CDRs) or pre-screening tools were developed. The
purpose of such tools is to categorize individuals according
to their risk status, to select most suitable candidates forOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Demographic profile of healthcare professional
(n = 170)
Variable N (%) Mean ± SD
Age 39.00 ± 7.89













General practitioners (GP’s) 47%
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of risk e.g. dietary and lifestyle modifications in low
to medium risk individuals while pharmacological ther-
apy for one with high risk (Schwartz & Steinberg 2006;
Elliott & Meek 2002). Ultimately use of osteoporosis
prescreening tools would result in better utilization of
bone densitometry, reduce economic burden associated
with osteoporosis as well as improved patient quality of
life (Tellier & Maeseneer 2001).
Aim of study
Current study is the first study conducted in Malaysia
with following aims:
 To analyze different approaches of pharmacists and
general practitioners towards availability and use of
osteoporosis prescreening tools
 To find out reasons that explain non utilization of
such tools in clinical practice
Methodology
As literature search did not show any study that explained
opinions of health care professional regarding availability,
awareness and use of osteoporosis pre-screening tools
or explains reasons for non-implementation of such
tools in clinical settings, therefore, a new question-
naire was developed to meet objectives of current
study.
The questionnaire so developed was composed of two
main parts. First part of questionnaire consisted of ques-
tions related to demographics i.e. age, race, gender, na-
tionality, number of years in practice and specialty. The
second part was composed of 11 questions regarding
awareness, availability, utility, and possible reasons for
non-implementation of existing pre-screening tools. All
questions were close ended questions with options yes,
no, don’t know. An excellent stability of questionnaire
was obtained as Pearson’s r product moment correlation
was 0.869.
Community pharmacies and General practitioners
based in Penang and registered with Ministry of health,
Malaysia were considered respondents for current
study. Dillmans total design survey method was followed
(Hoddinott & Bass 1986; Thorpe & Ryan 2009). Question-
naires along with consent form and a prepaid reply en-
velop were sent to participants via mailing. After three
weeks of first mail, a reminder letter was sent to those
who did not respond. Lastly a reminder letter was again
sent in 7th week for those participants who still did not
respond back. A total of 300 questionnaires were sent
i.e. 150 to each group. After 7th week, total 170 ques-
tionnaires were received back making overall response
rate of study as 56%. Statistical Package for Social Sciences
(SPSS version 16) was used to analyze data.Results
The demographic profile of participants is shown in
Table 1. Demographically majority of the study partici-
pants were male and belonged to Chinese ethnicity. First
four questions were designed to assess awareness of
CDRs while question 5, 6 and 7 were related to utility of
CDRs. Opinions of health care professional regarding
non-implementation of existing CDRs were assessed via
question 8 while practices of healthcare professional, re-
garding implementation of CDRs in future, were asked
in question 9 and 10. A list of different sources of infor-
mation was given in last question and participants were
requested to choose one source which they would like to
use in order to gain information regarding CDRs. The
frequency of responses for different questions in ques-
tionnaire is shown in Table 2. As clearly shown in
Table 2, (80.5%) of participants were not aware about
CDRs but surprisingly more participants were familiar
with term prescreening tools. Participants were then
asked to identify main purpose of prescreening tools.
Only 30.7% were able to identify that prescreening tools
are meant to identify or select risk group population.
Out of list of 8 prescreening tools, the only prescreening
tool that was identified by majority of participants was
FRAX (Fracture risk assessment tool developed by
WHO) while participants showed general lack of aware-
ness towards other prescreening tools. Though only
10.7% of participants had utilized such tools in clinical
practice yet majority of the participants were willing to
gain information about such tools and use prescreening
tools further in clinical settings. Majority of the partici-
pants (35.8%) agreed that the only barrier that poses
Table 2 Frequency of responses to different parts of questionnaire
Item no. Yes No Don’t know
1. Have you ever heard about term Clinical Decision rules (CDRs) 19% 47% 34%
2. Have you ever heard about pre-screening tools which is an alternative term for CDRs 31% 29% 40%
4. Are you familiar/aware with following osteoporosis prescreening tools?
4a. SCORE (simple calculated osteoporosis risk estimation) 7% 46% 47%
4b. OSIRIS (osteoporosis index of risk) 11% 37% 52%
4c. SOFSURF (study of osteoporosis fractures-study utilizing risk factors) 6% 37% 57%
4d. OSAT (osteoporosis self- assessment tool) 29% 29% 42%
4e. ORAI (osteoporosis risk assessment instrument) 0% 39% 61%
4f. WO-E (weight-only-EPIDOS) 1% 44% 55%
4g. MOST (Malaysian osteoporosis tool) 16% 31% 53%
4h. FRAX (Fracture assessment tool) 36% 23% 41%
5. If aware, have you ever utilized any osteoporosis prescreening tool? If yes, please mention name of tool: 11% 88% 1%
6. If utilized, do you think that use of such tools in clinical practice is practicable? 9% 2% 89%
7. Would you like to implement and use osteoporosis pre-screening tools in future? 47% 22% 31%
9. Would you like to aware general population about osteoporosis pre-screening tools? 53% 17% 30%
10. Would you suggest and motivate general population to undergo screening by such tools? 56% 16% 28%
3. According to you what is the main purpose of prescreening tools a b c d
a. To select high risk individuals 37% 12% 34% 17%
b. To educate general population about a disease
c. To develop a care plan for patients
d. None of the above
8. According to you, what is the most common barrier in implementation of such tools? a b c d
a. Low level of awareness regarding availability of osteoporosis prescreening tools 39% 18% 28% 15%
b. Lack of knowledge regarding utilization of such tools
c. Issues on reliability of results of such tools
d. None of the above
11. Which of the following ways would you prefer to gain knowledge about such tools? a b c d
a. Seminars 17% 16% 49% 18%
b. CE (continuous education) programs
c. Leaflets/Brochures
d. Internet
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awareness regarding availability and use of osteoporosis
prescreening tools. Participants were lastly asked to se-
lect their preferred way by which they would like to gain
information regarding osteoporosis prescreening tools
and majority of them have chosen leaflets or brochures
as their preferred way of gaining information. According
to participants this mode is more convenient, flexible
and less time consuming as compared to seminars and
continuous education (CE) programs.
Discussion
A total of 170 healthcare professionals participated in
current study making current response rate of study as56%. The reason for low response rate might be attrib-
uted to mailing nature of survey rather than personnel
interaction.
Majority (63%) were male while females represented
37% of study population. In order to assess awareness of
osteoporosis CDRs, participants were first asked whether
they have heard about CDRs or CPRs (Clinical predic-
tion rules). They were then further asked whether they
are familiar with the term pre-screening tools. Surpris-
ingly, more number of participants showed awareness
about prescreening tools. This shows the fact that al-
though prescreening tools is an alternative term used for
CDRs or CPRs, yet healthcare professional are more
familiar with the term prescreening tools rather than




Pharmacist group GPs’ group
Yes No/Don’t know Yes No/Don’t know
1 23% 77% 13% 87%
2 43% 57% 17% 83%
4a 10% 90% 4% 96%
4b 15% 85% 5% 95%
4c 6% 94% 5% 95%
4d 34% 66% 22% 78%
4e 0% 100% 0% 100%
4f 2% 98% 0% 100%
4g 20% 80% 10% 90%
4h 46% 54% 24% 76%
5 16% 84% 5% 95%
6 14% 86% 2% 98%
7 49% 51% 44% 56%
9 61% 39% 43% 57%
10 65% 35% 45% 55%
3 3a 3b 3c 3d 3a 3b 3c 3d
48% 8% 42% 1% 24% 16% 24% 35%
8 8a 8b 8c 8d 8a 8b 8c 8d
47% 21% 13% 18% 29% 15% 45% 10%
11 11a 11b 11c 11d 11a 11b 11c 11d
12% 23% 38% 26% 22% 7% 61% 9%
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model which was originally proposed by Pathman et al
in 1996, awareness is the first and foremost step that
would compel an individual to practically implement
knowledge into clinical practice (Pathman & Konrad
1996; Heneghan & Perera 2007). As seen in our study
only less than one third of healthcare professionals were
aware of availability of osteoporosis CDR’s or pre-
screening tools, this explains one of the major reason for
non-utilization of pre-screening tools in clinical practice.
Even majority of participants were not able to identify
main purpose of pre-screening tools. This again shows
lack of awareness and main hindrance in practical imple-
mentation of such tools. FRAX was the only osteopor-
osis prescreening tool that was identified by majority of
participants and surprisingly the only tool that was being
used in clinical practice. In past, various studies have
been conducted among healthcare professional regarding
adoption of clinical guidelines. Results of such studies
have shown that one of the main reasons that healthcare
professional would not adopt guidelines or wished to
know about guidelines would be lack of confidence in de-
velopers of guidelines or recommendations (Hayward &
Guyatt 1997; Carlsen & Norheim 2008). The possible
reason for awareness of FRAX as pre-screening tool
of osteoporosis might be due to increase trust of
healthcare professional in developers of FRAX, as FRAX
was developed by WHO. As WHO is a worldwide trusted
organization and also FRAX is the only pre-screening tool
that has been included in Clinical guidance in manage-
ment of osteoporosis published by Malaysian osteoporosis
foundation (2012), this might explains its increase aware-
ness, as compared to other prescreening tools, among
healthcare professional.
Mann–Whitney U test was used to observe differences
between scores of pharmacists and GPs. A p-value of
less than 0.05 was considered statistically significant. For
this purpose, each correct answer, positive attitude to-
wards CDR use or knowledge regarding existing Clinical
decision rules was given one mark. On the other hand,
incorrect answers, negative answer (no) or undecided
answers (don’t know) were given zero mark. Question
number 8 was exempted from this scoring system as
there is no well documented reason for non-utility of
Clinical decision rules, so participants can have their
own opinions. There was a statistically significant differ-
ence between mean rank score of both groups with
pharmacists scoring a mean rank score of 137.55 while
GP’s scoring a mean rank score of 78.05. A comparison
of responses of both groups to towards awareness and
use of CDRs’ is shown in Table 3. It clearly shows that
as compare to GPs’, pharmacists are not only well aware
about prescreening tools but they are also more willing
to implement such tools in clinical practice.Overall healthcare professional showed poor know-
ledge regarding availability and use of osteoporosis pre-
screening tools. But good part is that they were willing
to develop positive perspective towards pre-screening
tools as they were interested to use them in clinical
practice. According to trans-theoretical model (TTM),
various stages are involved in adoption of a new behav-
ior, strategy or recommendation (Velicer & Prochaska
1998). First stage is known as pre-contemplation phase.
In this stage an individual does not have sufficient aware-
ness regarding concerned issue. As seen in our study that
health care professional were unaware about availability of
osteoporosis pre-screening tools even they were unable
to recognize what are pre-screening tools and why
they are used. Second phase is the contemplation phase,
at this stage individual gets introduced to concerned issue.
In current study, the conduction of such study among
healthcare professional shifts healthcare professional from
pre-contemplation phase to contemplation phase. Third
phase in trans-theoretical model is known as preparation
phase. Individual will show willingness to adopt new be-
havior towards concerned issue in this phase. In our study,
majority of healthcare professional showed willingness to
use such tools in future. Next stage is the most important
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phase. The need of the hour is to educate healthcare pro-
fessionals regarding availability and use of such tools
so that they can enter action stage of TTM and utilize
prescreening tools in clinical settings.
Conclusions
Osteoporosis prescreening tools are widely available pre-
validated tools that can be utilized in clinical practice by
healthcare professionals in order to select high risk indi-
viduals and save cost associated with conventional bone
scanning. As healthcare professionals are currently un-
aware about availability and use of such tools there-
fore, future studies should focus on creating awareness and
educating healthcare professionals about these tools rather
than development of new osteoporosis pre-screening tools.
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